DaVita Inc (DVA)
132.08
-0.69
(-0.52%)
USD |
NYSE |
Apr 26, 09:42
DaVita Enterprise Value: 21.28B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 21.28B |
| April 24, 2024 | 21.28B |
| April 23, 2024 | 21.38B |
| April 22, 2024 | 21.26B |
| April 19, 2024 | 20.85B |
| April 18, 2024 | 20.70B |
| April 17, 2024 | 20.83B |
| April 16, 2024 | 21.02B |
| April 15, 2024 | 21.03B |
| April 12, 2024 | 21.08B |
| April 11, 2024 | 21.16B |
| April 10, 2024 | 21.22B |
| April 09, 2024 | 21.39B |
| April 08, 2024 | 21.36B |
| April 05, 2024 | 21.35B |
| April 04, 2024 | 21.30B |
| April 03, 2024 | 21.50B |
| April 02, 2024 | 21.48B |
| April 01, 2024 | 21.72B |
| March 28, 2024 | 21.74B |
| March 27, 2024 | 21.64B |
| March 26, 2024 | 21.50B |
| March 25, 2024 | 21.45B |
| March 22, 2024 | 21.40B |
| March 21, 2024 | 21.58B |
| Date | Value |
|---|---|
| March 20, 2024 | 21.81B |
| March 19, 2024 | 21.77B |
| March 18, 2024 | 21.65B |
| March 15, 2024 | 21.62B |
| March 14, 2024 | 21.56B |
| March 13, 2024 | 21.76B |
| March 12, 2024 | 21.84B |
| March 11, 2024 | 21.55B |
| March 08, 2024 | 21.49B |
| March 07, 2024 | 21.39B |
| March 06, 2024 | 21.21B |
| March 05, 2024 | 21.44B |
| March 04, 2024 | 20.67B |
| March 01, 2024 | 20.77B |
| February 29, 2024 | 20.77B |
| February 28, 2024 | 20.77B |
| February 27, 2024 | 20.83B |
| February 26, 2024 | 20.60B |
| February 23, 2024 | 20.62B |
| February 22, 2024 | 20.42B |
| February 21, 2024 | 20.24B |
| February 20, 2024 | 20.43B |
| February 16, 2024 | 20.36B |
| February 15, 2024 | 20.15B |
| February 14, 2024 | 20.46B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
15.39B
Minimum
Aug 27 2019
23.53B
Maximum
Aug 04 2021
19.22B
Average
18.93B
Median
Sep 16 2022
Enterprise Value Benchmarks
| Encompass Health Corp | 11.58B |
| HCA Healthcare Inc | 124.57B |
| Cardinal Health Inc | 25.38B |
| Integer Holdings Corp | 4.649B |
| Stryker Corp | 138.15B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 150.66M |
| Revenue (Quarterly) | 3.146B |
| Total Expenses (Quarterly) | 2.735B |
| EPS Diluted (Quarterly) | 1.62 |
| Gross Profit Margin (Quarterly) | 32.02% |
| Profit Margin (Quarterly) | 4.79% |
| Earnings Yield | 5.60% |
| Operating Earnings Yield | 13.01% |
| Normalized Earnings Yield | 5.826 |